Prolonged QT risk assessment in antipsychotic overdose using the QT nomogram

Annals of Emergency Medicine

Volumn 66, Issue 2, 2015, Pages 154-164

  Berling, Ingrid ^a   Isbister, Geoffrey K ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; DROPERIDOL; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PERICIAZINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TRIFLUOPERAZINE; ZIPRASIDONE; ZUCLOPENTHIXOL; SULPIRIDE; SULTOPRIDE;

ADULT; CARDIOVASCULAR RISK; CONFERENCE PAPER; DRUG OVERDOSE; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEART RATE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; TORSADE DES POINTES; ADOLESCENT; AGED; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; LONG QT SYNDROME; MIDDLE AGED; NOMOGRAM; PATHOPHYSIOLOGY; PROCEDURES; TACHYCARDIA; TORSADES DE POINTES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; DRUG OVERDOSE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; NOMOGRAMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SULPIRIDE; TACHYCARDIA; THIORIDAZINE; TORSADES DE POINTES; YOUNG ADULT;

EID: 84961291306     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2014.12.005     Document Type: Conference Paper

References (30)

1. J.Y. Leung, A.M. Barr, R.M. Procyshyn, and et al. Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system Pharmacol Ther 135 2012 113 122
2. N.A. Buckley, I.M. Whyte, and A.H. Dawson Cardiotoxicity more common in thioridazine overdose than with other neuroleptics J Toxicol Clin Toxicol 33 1995 199 204
3. W.A. Ray, C.P. Chung, K.T. Murray, and et al. Atypical antipsychotic drugs and the risk of sudden cardiac death N Engl J Med 360 2009 225 235
4. J.G. Reilly, S.A. Ayis, I.N. Ferrier, and et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients Lancet 355 2000 1048 1052
5. Y. Ozeki, K. Fujii, N. Kurimoto, and et al. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 34 2010 401 405
6. M.A. Denvir, A. Sood, R. Dow, and et al. Thioridazine, diarrhoea and torsades de pointe J R Soc Med 91 1998 145 147
7. E. Richelson, and T. Souder Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds Life Sci 68 2000 29 39
8. G.K. Isbister, and C.B. Page Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice Br J Clin Pharmacol 76 2013 48 57
9. M.D. Drici, W.X. Wang, X.K. Liu, and et al. Prolongation of QT interval in isolated feline hearts by antipsychotic drugs J Clin Psychopharmacol 18 1998 477 481
10. N.D. Sharma, H.S. Rosman, I.D. Padhi, and et al. Torsades de pointes associated with intravenous haloperidol in critically ill patients Am J Cardiol 81 1998 238 240
11. W.V. Vieweg, M. Hasnain, J.C. Hancox, and et al. Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports Psychopharmacology (Berl) 228 2013 515 524
12. C.B. Page, L.A. Calver, and G.K. Isbister Risperidone overdose causes extrapyramidal effects but not cardiac toxicity J Clin Psychopharmacol 30 2010 387 390
13. eTG complete 2014 Therapeutic Guidelines Limited
14. G.K. Isbister, L. Calver, F. Van Gorp, and et al. Inter-rater reliability of manual QT measurement and prediction of abnormal QT, HR pairs Clin Toxicol (Phila) 47 2009 884 888
15. A. Chan, G.K. Isbister, C.M. Kirkpatrick, and et al. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram QJM 100 2007 609 615
16. P. Davey How to correct the QT interval for the effects of heart rate in clinical studies J Pharmacol Toxicol Methods 48 2002 3 9
17. L.E. Friberg, G.K. Isbister, and S.B. Duffull Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses Br J Clin Pharmacol 61 2006 177 190
18. M. Malik, and A.J. Camm Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling Drug Saf 24 2001 323 351
19. R.G. Newcombe Two-sided confidence intervals for the single proportion: comparison of seven methods Stat Med 17 1998 857 872
20. G.K. Isbister, L.E. Friberg, B. Stokes, and et al. Activated charcoal decreases the risk of QT prolongation after citalopram overdose Ann Emerg Med 50 2007 593 600 e1-46
21. L.E. Friberg, G.K. Isbister, L.P. Hackett, and et al. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach J Pharmacokinet Pharmacodyn 32 2005 571 605
22. G.K. Isbister, L.E. Friberg, L.P. Hackett, and et al. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal Clin Pharmacol Ther 81 2007 821 827
23. G.K. Isbister, C.R. Balit, D. Macleod, and et al. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes J Clin Psychopharmacol 30 2010 391 395
24. C.R. Balit, G.K. Isbister, L.P. Hackett, and et al. Quetiapine poisoning: a case series Ann Emerg Med 42 2003 751 758
25. The Australian Government group. Quetiapine and QT prolongation 2014 Medicines Safety Update: Australian Prescriber 21
26. N.A. Buckley, and P. Sanders Cardiovascular adverse effects of antipsychotic drugs Drug Saf 23 2000 215 228
27. B. Silke, C. Campbell, and D.J. King The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability J Psychopharmacol 16 2002 355 360
28. S. Kongsamut, J. Kang, X.L. Chen, and et al. A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs Eur J Pharmacol 450 2002 37 41
29. K. Titier, M. Canal, E. Deridet, and et al. Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice Toxicol Appl Pharmacol 199 2004 52 60
30. C. Newton-Cheh, M.G. Larson, D.C. Corey, and et al. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: the Framingham Heart Study Heart Rhythm 2 2005 277 284